Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Pharma/Biotech
Recent news which mentions Pharma/Biotech
< Previous
1
2
...
26
27
28
29
30
31
32
33
Next >
Corona Doom 2.0: Vaccine Passports
October 08, 2021
Tickers
BNTX
LPI
PFE
SI
Tags
Healthcare
Market News
Stocks / Equities
From
TalkMarkets
Tilray Stock Breaks Below Pattern: What's Next For The Cannabis Stock?
October 07, 2021
Tickers
TLRY
Tags
Market News
Consumer Goods
Stocks / Equities
From
TalkMarkets
Best Pharmaceutical Stocks To Buy In 2021
October 06, 2021
Tickers
ABBV
BMY
DVAX
GSK
Tags
Market News
Healthcare
Stocks / Equities
From
TalkMarkets
Market Briefing For Wednesday, Oct. 6
October 06, 2021
Tickers
AAPL
AEHR
AMZN
GOOGL
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Market Briefing For Tuesday, Oct. 5
October 05, 2021
Tickers
AEHR
AMZN
FB
GM
Tags
Market News
Technology
Basic Materials / Commodities
From
TalkMarkets
The Week Ahead In Biotech (Oct. 3-9): ChemoCentryx FDA Decision, Conference Presentations, IPOs, And More
October 03, 2021
Tickers
ASND
BCYC
CCXI
MRK
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
7 Monster Stock Market Predictions – The Week Of Oct. 4 Edition
October 03, 2021
Tickers
F
MRK
MU
SPY
Tags
Capital & Industrial Goods
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
Week In Review: Innovent Acquires Novel Atopic Dermatitis Treatment In $267 Million Pact
October 02, 2021
Tags
Healthcare
Market News
Stocks / Equities
From
TalkMarkets
Take A Look At The Top-Performing Biotech ETFs YTD
October 02, 2021
Tickers
BBH
BIB
BNTX
IBB
Tags
Pharma/Biotech
Stocks / Equities
ETFs
From
TalkMarkets
September Summary: Cannabis-Based Vs. Psychedelic Compounds-Based Drug Stock Performances
October 01, 2021
Tickers
ALID
CRBP
ENVB
FTRP
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
3 Cannabis Stocks to Avoid in October
September 30, 2021
Tickers
HRVSF
OGI
TRSSF
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Merck-Acceleron Deal Would Come With Side Effects
September 30, 2021
Tickers
MRK
XLRN
Tags
Market News
Pharma/Biotech
From
TalkMarkets
Market Briefing For Wednesday, Sept. 29
September 29, 2021
Tickers
SPX
SRNE
Tags
Bonds
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
4 No-Brainer Pharmaceutical Stocks to Buy in October
September 27, 2021
Tickers
ALPMY
AZN
GSK
JNJ
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Biotech Playbook Revisited As Technicals Weaken
September 27, 2021
Tickers
ARKG
CRSP
CYRX
EDIT
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
Aurora Cannabis Stock Price under Pressure Ahead of Q4 FY2021 Earnings
September 27, 2021
Tickers
ACB
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Pfizer CEO Says People Needing COVID-19 Vaccines Every Year Is The 'Most Likely Scenario'
September 27, 2021
Tickers
BNTX
MRNA
PFE
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Bristol Myers: Worries Create Opportunity
September 26, 2021
Tickers
BMY
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Week In Review: Broncus Stages $200 Million Hong Kong IPO For Pulmonary Devices
September 25, 2021
Tickers
HCM
PFE
Tags
Healthcare
Market News
Pharma/Biotech
From
TalkMarkets
CDC Approves Pfizer COVID Booster For Over 65 Adults, Younger With At-risk Jobs
September 24, 2021
Tickers
BNTX
PFE
Tags
Healthcare
Market News
Pharma/Biotech
From
TalkMarkets
Will Pfizer ETFs Soar on FDA's COVID-19 Vaccine Booster Approval?
September 24, 2021
Tickers
BNTX
FDL
IEIH
IHE
Tags
Market News
Healthcare
ETFs
From
TalkMarkets
Aurora Cannabis To Close Down Edmonton-Based Facility
September 22, 2021
Tickers
ACB
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
The Writing Was On The Wall For Pfizer – If You Use Volume Price Analysis!
September 22, 2021
Tickers
PFE
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Market Briefing For Wednesday, Sept. 22
September 22, 2021
Tickers
AAL
EGRNF
FDX
JBLU
Tags
Financial
Transportation
Market News
From
TalkMarkets
The Three Psychedelics ETFs: Which Is The Best Fit For Your Portfolio?
September 21, 2021
Tickers
CLABF
CMPS
CYBN
FTRP
Tags
Pharma/Biotech
ETFs
Market News
From
TalkMarkets
Cannabis Drug Stocks Have Mirrored Performance Of Psychedelic Drug Stocks To Date In September
September 20, 2021
Tickers
ALID
AWKNF
CRBP
CYBN
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Tilray's Stock Could Be In For A Ugly Move If It Can't Hold Above A Key Level
September 20, 2021
Tickers
CGC
TLRY
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Pharma, Tech and Finance
September 20, 2021
Tickers
AUPH
AZN
GRFS
KL
Tags
Market News
Healthcare
Financial
From
TalkMarkets
11 Cannabis Stocks That Have Moved Significantly In September
September 20, 2021
Tickers
ACB
ALEAF
CBWTF
CGC
Tags
Healthcare
Market News
Stocks / Equities
From
TalkMarkets
Canopy Growth's Stock Dips After Analyst Cuts Price On Lower Sales, Confesses Preference For Tilray
September 20, 2021
Tickers
CGC
TLRY
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
< Previous
1
2
...
26
27
28
29
30
31
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.